Clinical Trial Update: A Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease in Patients Taking Levodopa [Phase 2]

View source ↗

Summary

This update reports the completion of a Phase 2 trial evaluating istradefylline (KW-6002) as add-on therapy to levodopa in Parkinson's disease patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• istradefylline (istradefylline)

Snippet

Sponsor: Kyowa Kirin Co., Ltd. | Conditions: Parkinson's Disease | Phase 2 | Status: COMPLETED